We studied DDRs in cells from heterozygous ABRAXAS1-mutation carriers to understand whether breast cancer-associated mutations in the gene encoding the BRCA1 complex partner ABRAXAS1 entail similar phenotypic changes as described for BRCA1-mutations. Here, ABRAXAS1 is linked to breast carcinoma.